NTLA

SEC source: 0000950170-25-001232 · ownership.xml · nonDerivative · entry 1

Sepp-Lorenzino Laura · CIK 0001777421 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F2 · balance_after: Includes 405 and 556 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2024 and December 31, 2024, respectively.

SEC source: 0000950170-25-001236 · ownership.xml · derivative · entry 3

LEONARD JOHN M · CIK 0001563584 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,850 shares

Expires 2031-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 3, 2021, the reporting person was granted 31,394 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter.

SEC source: 0000950170-25-001236 · ownership.xml · nonDerivative · entry 1

LEONARD JOHN M · CIK 0001563584 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 967,922

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

SEC source: 0000950170-24-112980 · ownership.xml · nonDerivative · entry 1

Dube Michael P · CIK 0002019493 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,012

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2024, and does not represent a volitional trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.95 to $19.01, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 2, 2024 at each separate price.

SEC source: 0000950170-24-086061 · ownership.xml · derivative · entry 2

Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,219

Underlying: Common Stock · 96,219 shares

Expires 2034-07-21

F2 · derivative.exercise_date: This option was granted on July 22, 2024 with respect to shares of Common Stock, with 33% vesting on July 22, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-086061 · ownership.xml · nonDerivative · entry 1

Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,324

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-081258 · ownership.xml · nonDerivative · entry 1

Dube Michael P · CIK 0002019493 · VP, PAO and Interim PFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,024

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-081259 · ownership.xml · nonDerivative · entry 1

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,470

F1 · kind: Sale of 405 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 28, 2024.

SEC source: 0000950170-24-075718 · ownership.xml · nonDerivative · entry 1

Verwiel Frank · CIK 0001545794 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,948

F1 · kind: The reported sale of 1,505 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 7, 2024.

SEC source: 0000950170-24-074383 · ownership.xml · derivative · entry 2

Goff Brian · CIK 0001546216 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,297

Underlying: Common Stock · 22,297 shares

Expires 2034-06-12

F2 · derivative.exercise_date: This option was granted on June 13, 2024 with respect to 22,297 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 33 1/3 % vesting on June 13, 2025 and the remaining 66 2/3% vesting in 8 substantially equal quarterly installments thereafter.

SEC source: 0000950170-24-074383 · ownership.xml · nonDerivative · entry 1

Goff Brian · CIK 0001546216 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,409

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-073700 · ownership.xml · derivative · entry 2

GOODMAN JESSE · CIK 0001756929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,515

Underlying: Common Stock · 11,515 shares

Expires 2034-06-11

F2 · derivative.exercise_date: This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-24-073700 · ownership.xml · nonDerivative · entry 1

GOODMAN JESSE · CIK 0001756929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,453

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-073704 · ownership.xml · derivative · entry 2

Verwiel Frank · CIK 0001545794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,515

Underlying: Common Stock · 11,515 shares

Expires 2034-06-11

F2 · derivative.exercise_date: This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-24-073704 · ownership.xml · nonDerivative · entry 1

Verwiel Frank · CIK 0001545794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,453

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-073702 · ownership.xml · derivative · entry 2

Keresty Georgia · CIK 0001773532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,515

Underlying: Common Stock · 11,515 shares

Expires 2034-06-11

F2 · derivative.exercise_date: This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-24-073702 · ownership.xml · nonDerivative · entry 1

Keresty Georgia · CIK 0001773532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,883

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-073689 · ownership.xml · derivative · entry 2

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,515

Underlying: Common Stock · 11,515 shares

Expires 2034-06-11

F2 · derivative.exercise_date: This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-24-073689 · ownership.xml · nonDerivative · entry 1

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,453

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-073685 · ownership.xml · derivative · entry 2

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,515

Underlying: Common Stock · 11,515 shares

Expires 2034-06-11

F2 · derivative.exercise_date: This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-24-073685 · ownership.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,733

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-073680 · ownership.xml · derivative · entry 2

CHASE WILLIAM J · CIK 0001563572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,515

Underlying: Common Stock · 11,515 shares

Expires 2034-06-11

F2 · derivative.exercise_date: This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-24-073680 · ownership.xml · nonDerivative · entry 1

CHASE WILLIAM J · CIK 0001563572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,693

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-025906 · ownership.xml · nonDerivative · entry 2

BASTA JAMES · CIK 0001792726 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,571

F2 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2024, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-24-025902 · ownership.xml · nonDerivative · entry 2

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,470

F2 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2024, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-24-025904 · ownership.xml · derivative · entry 2

Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,855

Underlying: Common Stock · 55,855 shares

Expires 2034-02-28

F2 · derivative.exercise_date: This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-025904 · ownership.xml · nonDerivative · entry 1

Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,073

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-025907 · ownership.xml · derivative · entry 2

Sepp-Lorenzino Laura · CIK 0001777421 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,794

Underlying: Common Stock · 54,794 shares

Expires 2034-02-28

F2 · derivative.exercise_date: This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-025907 · ownership.xml · nonDerivative · entry 1

Sepp-Lorenzino Laura · CIK 0001777421 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,893

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-025906 · ownership.xml · derivative · entry 3

BASTA JAMES · CIK 0001792726 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,752

Underlying: Common Stock · 46,752 shares

Expires 2034-02-28

F3 · derivative.exercise_date: This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-025906 · ownership.xml · nonDerivative · entry 1

BASTA JAMES · CIK 0001792726 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,868

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-025903 · ownership.xml · derivative · entry 2

Hicks Derek · CIK 0001901282 · EVP, Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,421

Underlying: Common Stock · 42,421 shares

Expires 2034-02-28

F2 · derivative.exercise_date: This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-025903 · ownership.xml · nonDerivative · entry 1

Hicks Derek · CIK 0001901282 · EVP, Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,380

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-025902 · ownership.xml · derivative · entry 3

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,072

Underlying: Common Stock · 45,072 shares

Expires 2034-02-28

F3 · derivative.exercise_date: This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-025902 · ownership.xml · nonDerivative · entry 1

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,075

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-025900 · ownership.xml · derivative · entry 3

LEONARD JOHN M · CIK 0001563584 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,929

Underlying: Common Stock · 163,929 shares

Expires 2034-02-28

F3 · derivative.exercise_date: This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-025900 · ownership.xml · nonDerivative · entry 1

LEONARD JOHN M · CIK 0001563584 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 960,072

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-025901 · ownership.xml · derivative · entry 2

Goddard Glenn · CIK 0001581992 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,316

Underlying: Common Stock · 41,316 shares

Expires 2034-02-28

F2 · derivative.exercise_date: This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-025901 · ownership.xml · nonDerivative · entry 1

Goddard Glenn · CIK 0001581992 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,213

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-24-003632 · ownership.xml · nonDerivative · entry 2

Sepp-Lorenzino Laura · CIK 0001777421 · EVP, Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,927

F1 · kind: The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.19 to $29.63, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 8, 2024 at each separate price.

SEC source: 0000950170-24-003632 · ownership.xml · nonDerivative · entry 1

Sepp-Lorenzino Laura · CIK 0001777421 · EVP, Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,594

F1 · kind: The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.16 to $29.06, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 8, 2024 at each separate price.

SEC source: 0000950170-24-002515 · ownership.xml · nonDerivative · entry 1

Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,372

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-24-002514 · ownership.xml · nonDerivative · entry 1

Sepp-Lorenzino Laura · CIK 0001777421 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,202

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-24-002516 · ownership.xml · nonDerivative · entry 1

LEONARD JOHN M · CIK 0001563584 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 846,486

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-24-002511 · ownership.xml · nonDerivative · entry 1

Goddard Glenn · CIK 0001581992 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,585

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-24-002507 · ownership.xml · nonDerivative · entry 1

Hicks Derek · CIK 0001901282 · EVP, Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,987

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1 and January 3, 2024, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-24-002504 · ownership.xml · nonDerivative · entry 1

BASTA JAMES · CIK 0001792726 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,474

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-24-002502 · ownership.xml · nonDerivative · entry 2

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,845

F2 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-24-002502 · ownership.xml · nonDerivative · entry 1

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,146

F1 · kind: Sale of 307 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2023.

SEC source: 0000950170-24-001204 · ownership.xml · derivative · entry 2

Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,189

Underlying: Common Stock · 3,187 shares

Expires 2031-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 3, 2021, the reporting person was granted 12,750 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter.